ConsortiEX Blog

ConsortiEX and LedgerDomain Announce Strategic Partnership

MILWAUKEE, March 13, 2024 – ConsortiEX, an industry leader in compliance and patient-safety focused software and services for outsourcing and hospital pharmacies, is pleased to announce a new strategic partnership with LedgerDomain, a pioneering identity and secure messaging platform tailored for modern decentralized[...]

Customer Spotlight | Duke University Health System

FDA Provides new Guidance to 503A Compounding Facilities

Oct. 21, 2021 - MILWAUKEE

ConsortiEX Participates in ISMP Summit for Sterile Compounding Technology

The Institute for Safe Medication Practices (ISMP) recently held their annual Sterile Product Compounding Safety Summit. The goal of the summit is to continue the conversations around safe practices related to the use of sterile compounding workflow software, automated compounding devices and robotic compounding[...]

Utilizing a Compounding Management System to Support Emergency Response

Customer Spotlight | Indiana University Health

Managing COVID-19 With the Assure-Trak® Compounding Management System

With the national rollout of the COVID-19 vaccine already underway, healthcare facilities nationwide are being faced with the challenge of balancing safety, documentation, and efficiency, in their protocols for vaccine distribution.

Recent FDA Guidance Sparks Concerns from Industry Leaders

Several key industry players have issued responses to the FDA in regard to the recent draft guidance on the use of Product Identifiers, and the policy on grandfathered product, in compliance with the Drug Supply Chain Security Act (DSCSA).

FDA Releases Final Guidance on Upcoming Product Identifier Requirements

On Sep. 9, 2018, the FDA released a Final Guidance regarding the use of product identifiers on packages and homogenous cases of product as mentioned in the Drug Supply Chain Security Act (DSCSA).



See all